Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 719

    1.

    Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

    Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM.

    Diabetes. 2006 Jul;55(7):2098-105.PMID: 16804081 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    3.

    Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.

    Yang W, Hussain S, Mi QS, Santamaria P, Delovitch TL.

    J Immunol. 2004 Oct 1;173(7):4407-16.PMID: 15383571 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development.

    Manirarora JN, Kosiewicz MM, Parnell SA, Alard P.

    PLoS One. 2008;3(11):e3739. Epub 2008 Nov 17.PMID: 19011680 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    CD3 antibody treatment stimulates the functional capability of regulatory T cells.

    Chatenoud L.

    Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.PMID: 14609225 [PubMed - indexed for MEDLINE]Related articles

    6.

    Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.

    Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.

    Ann N Y Acad Sci. 2005 Jun;1051:72-87. Review.PMID: 16126946 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background.

    Koarada S, Wu Y, Olshansky G, Ridgway WM.

    J Immunol. 2002 Dec 1;169(11):6580-7.PMID: 12444170 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?

    Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B.

    Gene Ther. 2004 Oct;11(20):1487-96.PMID: 15343360 [PubMed - indexed for MEDLINE]Related articles

    12.

    CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.

    Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST.

    Diabetes. 2009 Jul;58(7):1568-77. Epub 2009 Mar 31.PMID: 19336675 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.

    Mellanby RJ, Thomas D, Phillips JM, Cooke A.

    Immunology. 2007 May;121(1):15-28.PMID: 17428252 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.

    Yadav D, Judkowski V, Flodstrom-Tullberg M, Sterling L, Redmond WL, Sherman L, Sarvetnick N.

    J Immunol. 2004 Sep 15;173(6):3631-9.PMID: 15356107 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    T-cell compartments of prediabetic NOD mice.

    Berzins SP, Venanzi ES, Benoist C, Mathis D.

    Diabetes. 2003 Feb;52(2):327-34.PMID: 12540604 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.

    Wu AJ, Hua H, Munson SH, McDevitt HO.

    Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12287-92. Epub 2002 Sep 9.PMID: 12221281 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.

    Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N.

    J Immunol. 2004 Oct 1;173(7):4331-41.PMID: 15383562 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.

    Keino H, Takeuchi M, Kezuka T, Hattori T, Usui M, Taguchi O, Streilein JW, Stein-Streilein J.

    Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1047-55.PMID: 16505040 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.

    Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R.

    J Exp Med. 2005 Apr 18;201(8):1333-46.PMID: 15837817 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

    Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM.

    J Exp Med. 2004 Jun 7;199(11):1467-77.PMID: 15184500 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data